• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,360.01 13.84
( 0.02%)
Global Indices
Nasdaq
50,746.98 -581.81
(-1.13%)
Dow Jones
7,576.82 -53.96
(-0.71%)
Hang Seng
67,369.16 -1,032.97
(-1.51%)
Nikkei 225
10,347.89 15.59
(0.15%)
Forex
USD-INR
95.24 0.16
(0.17%)
EUR-INR
110.83 0.16
(0.15%)
GBP-INR
128.25 0.32
(0.25%)
JPY-INR
0.60 0.00
(0.02%)

EQUITY - MARKET SCREENER

Fredun Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
539730
INE194R01017
514.6538079
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
38.59
1281.42
EPS(TTM)
Face Value()
Div & Yield %
60.24
10
0
 

Bombay Dyeing Q4 PAT jumps 82% YoY to Rs 21 cr
May 09,2026

Revenue from operations increased 10.3% year-on-year to Rs 395.84 crore for the quarter ended 31 March 2026.

Total expenses declined 11.17% year-on-year to Rs 362.43 crore during the quarter. The cost of raw materials fell 26.78% to Rs 204.10 crore, while employee benefit expenses surged 451.07% YoY to Rs 48.99 crore.

On a segmental basis, polyester revenue stood at Rs 367.05 crore (up 11.45% YoY), while the real estate business stood at Rs 18.70 crore (down 8.65% YoY) and revenue from the retail / textile segment stood at Rs 6.84 crore (down 25.65% YoY) during the period under review.

On a full-year basis, the company’s consolidated net profit tanked 94.5% to Rs 26.92 crore on a 9% decline in net sales to Rs 1,460.33 crore in FY26 over FY25.

Bombay Dyeing & Manufacturing Company is currently engaged in the business of real estate development, polyester staple fiber, and retail (textiles).

The scrip shed 0.26% to end at Rs 135.60 on Friday, 8 May 2026.